Skip to content
10-Q

Quarterly Report

ARYA SCIENCES ACQUISITION CORP V

0001140361-23-024396

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$89.21K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$72.16K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $295.97K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $385.19K
Cash And Equivalents Q1 2023 · Mar 31, 2022 $703.72K
Cash And Equivalents Q1 2023 · Dec 31, 2021 $775.89K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$5.05M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$4.85M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$6.96M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$6.68M
Current Liabilities Q1 2023 · Mar 31, 2023 $2.96M
Current Liabilities Q1 2023 · Dec 31, 2022 $2.88M
Total Liabilities Q1 2023 · Mar 31, 2023 $5.58M
Total Liabilities Q1 2023 · Dec 31, 2022 $5.49M
Current Assets Q1 2023 · Mar 31, 2023 $425.97K
Current Assets Q1 2023 · Dec 31, 2022 $542.19K
Total Assets Q1 2023 · Mar 31, 2023 $153.72M
Total Assets Q1 2023 · Dec 31, 2022 $152.14M
Sga Expense Q1 2023 · Mar 31, 2023 $201.87K
Sga Expense Q1 2023 · Mar 31, 2022 $228.53K
Net Income Q1 2023 · Mar 31, 2023 $1.49M
Net Income Q1 2023 · Mar 31, 2022 −$278.16K
Operating Income Q1 2023 · Mar 31, 2023 −$201.87K
Operating Income Q1 2023 · Mar 31, 2022 −$228.53K